Composition of unapproved cannabinoid products directly marketed to Canadian pet owners

摘要

On October 17, 2018 the Cannabis Act came into effect in Canada legalizing activities associated with the production, distribution, sale, and consumption of cannabis. A legal framework exists for physicians to authorize cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). However, this option is currently unavailable to Canadian veterinarians despite calls for revision by the Canadian Veterinary Medical Association (CVMA) (https://www.canadianveterinarians.net/documents/cvma-letter-to-hc-proposed-approach-to-regulation-of-cannabis). Therefore Canadian veterinarians are currently unable to authorize the use of cannabis-derived products for their patients, despite apparent interest from Canadian pet owners (1).